Business & Finance

Edwards Lifesciences reports solid third quarter earnings

Published in Cardiovascular Business Week, November 21st, 2006

Edwards Lifesciences Corporation (EW) reported net income for the quarter ended September 30, 2006 of $27.8 million, or $0.45 per diluted share, compared to a net loss of $4.4 million, or $0.07 per diluted share, for the same period in 2005.

Non-GAAP net income, which excludes the special items detailed in the reconciliation table below and the impact of option expense under FAS 123(R), grew to $32.5 million compared to $29.0 million for the same period last year. Non-GAAP earnings per diluted share grew 15.2% to $0.53 compared to $0.46 per share for the same period in the prior year.

Third quarter net sales increased 2.7% to $247.4 million, compared...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2006-11-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry